How Morris was paid
$600,000 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Total |
|---|---|---|---|---|
| Ronnie MorrisChief Executive Officer | $400,000 | $200,000 | — | $600,000 |
| David MillerChief Financial Officer | $278,333 | $30,000 | $7,444 | $315,777 |
| Brady DavisPresident | $177,083 | — | — | $177,083 |
What changed and why
- $600K2025 CEO total was $600,000 versus $400,000 in 2024; the table reports a $200,000 bonus.
- 50%50% was Morris’s annual bonus target, with a 75% maximum payout.
- $278KDavid Miller’s 2025 salary was $278,333, including current base salary of $315,000 and previous salary of $260,000.
- $177KBrady Davis’s 2025 salary was $177,083, prorated through October 2024 following his death.
- None of Davis’s equity awards had vested at death and were forfeited.
- $7,444Miller received a $7,444 option award in 2025.
Other Champions Oncology proxy statements
- 2026 proxy statement
Robert Brainin paid $3.6M.
Filed Aug 28, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.